Stempoint Capital LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY | $2.56M | 0.4% |
| MBX Biosciences, Inc.MBX | $2.48M | 0.4% |
| QUINCE THERAPEUTICS INC | $2.48M | 0.4% |
| Avalo Therapeutics, Inc. | $2.46M | 0.4% |
| Invivyd, Inc. | $2.44M | 0.4% |
| MEIRAGTX HLDGS PLC | $2.29M | 0.4% |
| INVENTIVA SA | $2.17M | 0.4% |
| AbbVie Inc. | $2.13M | 0.4% |
| ADC THERAPEUTICS SA | $1.77M | 0.3% |
| MAPLIGHT THERAPEUTICS INCMPLT | $1.76M | 0.3% |
| Pharvaris N.V. | $1.62M | 0.3% |
| LEGEND BIOTECH CORPLEGN | $1.59M | 0.3% |
| BELITE BIO, INCBLTE | $1.47M | 0.3% |
| XILIO THERAPEUTICS INC | $1.30M | 0.2% |
| Evommune, Inc.EVMN | $1.17M | 0.2% |
| BridgeBio Oncology Therapeutics, Inc.BBOT | $1.08M | 0.2% |
| SPYRE THERAPEUTICS, INC. | $1.06M | 0.2% |
| UNIQURE NV | $1.04M | 0.2% |
| Taysha Gene Therapies, Inc.TSHA | $1.00M | 0.2% |
| Monte Rosa Therapeutics, Inc. | $965.5K | 0.2% |
| SAB Biotherapeutics, Inc. | $548.1K | 0.1% |
| VANDA PHARMACEUTICALS INC | $520.3K | 0.1% |
| CAPRICOR THERAPEUTICS, INC. | $515.2K | 0.1% |
| Pasithea Therapeutics Corp.KTTA | $458.1K | 0.1% |
| Vistagen Therapeutics, Inc.VTGN | $142.1K | 0.0% |